Team discovers genetic cause of rare high blood pressure syndrome

February 6, 2018, Berlin Institute of Health
Team discovers genetic cause of rare high blood pressure syndrome
Credit: Berlin Institute of Health

Twenty-five years ago, an unusual inherited form of high blood pressure was first described in an Australian family. Its genetic cause, however, had remained elusive. Using modern sequencing methods, an international research team led by BIH Johanna Quandt Professor Ute Scholl has succeeded in detecting mutations in a new disease gene (CLCN2)—present in this family and seven others—that are responsible for the development of a familial form of hyperaldosteronism.

More than a billion people worldwide suffer from high (hypertension). Prolonged hypertension damages blood vessels, which can result in damage to the heart, kidneys, and brain. Possible consequences include heart attack, kidney failure and stroke. Besides such factors as obesity, salt consumption, and alcohol intake, genetic factors play an important role in the development of hypertension. In some rare cases, familial hypertension is caused by mutations within single genes. These play important roles in blood pressure determination, and mutations typically cause early-onset hypertension, even in young children and adolescents. Ute Scholl and a team of scientists from the United States and Australia have now identified a new hypertension disease gene. The study focused on a particular and very rare form of high blood pressure, known as familial hyperaldosteronism type II. This inherited disease causes the to produce too much aldosterone—a hormone that regulates how much salt and water the kidneys retain in the body. Too much of this hormone results in .

Mutation in the CLCN2 gene alters blood pressure regulation

Familial hyperaldosteronism type II was first described in an Australian family 25 years ago. The research team investigated this family along with other patients suffering from hyperaldosteronism in childhood and adolescence. A total of eight families, including the large Australian family, showed mutations in a gene that had not previously been associated with . The CLCN2 gene carries information for building a channel in the cell membrane through which chloride ions can pass. In specific cells of the adrenal gland, these chloride channels regulate membrane voltage and aldosterone production. Gene mutations in patients with familial hyperaldosteronism cause changes in the membrane voltage and result in the overproduction of aldosterone, which raises .

Study results enable early detection and treatment

Lead author Ute Scholl says, "Patients with suspected familial hyperaldosteronism and their relatives will benefit from our findings because in the future, they can be screened for in the CLCN2 gene."

Study patients also responded to medication that is already used in the treatment of hyperaldosteronism. "For families with familial hyperaldosteronism type II, identifying the genetic cause doesn't just help with early detection of the disease, it also enables targeted treatment," says Scholl. As BIH Johanna Quandt Professor, Ute Scholl and her research group will now use the results from the study to delve deeper into their research at the Berlin Institute of Health. "We plan to further investigate the role of chloride channels in the adrenal gland," says Scholl. "We also try to better understand the regulation of these channels in order to develop improved treatment strategies."

Explore further: Research suggests new pathways for hyperaldosteronism

More information: Ute I. Scholl et al, CLCN2 chloride channel mutations in familial hyperaldosteronism type II, Nature Genetics (2018). DOI: 10.1038/s41588-018-0048-5

Related Stories

Research suggests new pathways for hyperaldosteronism

December 7, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP), in collaboration with researchers at Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the ...

Scientists discover a curable cause for some cases of high blood pressure

August 5, 2013
Five per cent of high blood pressure cases are caused by small nodules on hormone gland; now scientists have developed a scan which enables rapid diagnosis.

Simple blood tests lead to improved hypertension treatment in African countries

May 2, 2017
Using two simple blood tests, Western University researchers were able to drastically improve treatment for resistant hypertension across three sites in Nigeria, Kenya and South Africa.

Endocrine Society experts call for expanded screening for primary aldosteronism

April 26, 2016
The Endocrine Society today issued a Clinical Practice Guideline calling on physicians to ramp up screening for primary aldosteronism, a common cause of high blood pressure.

Researchers use a pump-induced disease to define underlying molecular mechanism

October 26, 2017
Researchers at Texas Tech University Health Sciences Center (TTUHSC) investigated a pump-induced disease and defined the molecular mechanism that triggers it. The study, "On the effect of hyperaldosteronism-inducing mutations ...

Diagnostic mutations ID'd in chronic kidney disease patients

December 5, 2017
(HealthDay)—About one-quarter of adults with chronic kidney disease (CKD) of unknown cause or familial nephropathy or hypertension have diagnostic mutations, which can be identified with whole-exome sequencing (WES), according ...

Recommended for you

Officials remove special rules for gene therapy experiments

August 16, 2018
U.S. health officials are eliminating special regulations for gene therapy experiments, saying that what was once exotic science is quickly becoming an established form of medical care with no extraordinary risks.

Genetic link discovered between circadian rhythms and mood disorders

August 15, 2018
Circadian rhythms are regular 24-hour variations in behaviour and activity that control many aspects of our lives, from hormone levels to sleeping and eating habits.

Ovarian cancer genetics unravelled

August 14, 2018
Patterns of genetic mutation in ovarian cancer are helping make sense of the disease, and could be used to personalise treatment in future.

New genome-editing strategy could lead to therapeutics

August 14, 2018
Researchers at UMass Medical School have developed a genome-editing strategy to correct disease-causing DNA mutations in mouse models of human genetic diseases, according to research published in the Aug. 18 edition of Nature ...

Study reveals broad 'genetic architectures' of traits and diseases

August 13, 2018
Scientists at Johns Hopkins Bloomberg School of Public Health have developed a powerful method for characterizing the broad patterns of genetic contributions to traits and diseases. The new method provides a "big picture" ...

Genetic tools uncover cause of childhood seizure disorder missed by other methods

August 13, 2018
Early childhood seizures result from a rare disease that begin in the first months of life. Researchers at University of Utah Health have developed high-tech tools to uncover the genetic cause of the most difficult to diagnose ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.